Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1751 to 1775 of about 5897

Previous 25

Website Changes

12/31/2015

Added a nice survivor story with a picture of a nice lady wearing the Optune device. In 1 photo she shows it off, in the other she hides it.

12/24/2015

The Musella Foundation has awarded another pediatric brain tumor research grant

12/23/2015

Study Finds Mechanism That Causes Normal Cells to Become Cancerous

12/21/2015

Recurrent venous thromboembolism in glioblastoma.

12/20/2015

IBTA Newsletter

12/19/2015

Brain cancer patient beats odds with experimental treatment

12/15/2015

Experimental drugs that change energy supply in cells could slow brain tumor growth

12/15/2015

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma

12/14/2015

New Data on Tumor Treating Fields’ Anti-Mitotic Mechanism of Action Published in Scientific Reports

12/14/2015

Roche`s Alecensa Granted Accelerated FDA Approval in Lung Cancer

12/13/2015

Patient with Brain Tumor Responds Dramatically to Targeted Therapy

12/12/2015

The Musella Foundation has awarded a pediatric brain tumor research grant

12/12/2015

A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas.

12/12/2015

First Patient Enrolled in Toca 5, Tocagen’s Phase 2/3 Clinical Trial in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma

12/08/2015

Novocure (NVCR) Issues Positive Update on TTFields Study in Certain Glioblastoma Patients

11/27/2015

Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme

11/27/2015

Experimental brain cancer treatment offers family hope

11/25/2015

The Musella Foundation announced that it has awarded a $50,000 brain tumor research grant to Ninh Doan, MD, PhD, of the Medical College of Wisconsin.

11/23/2015

Combination of bevacizumab and lomustine with first recurrence of glioblastoma prolongs PFS but not OS

11/23/2015

Tocagen Presents Interim Data from Studies Evaluating Toca 511 & Toca FC at the Annual Meeting of the Society for Neuro-Oncology (SNO)

11/22/2015

Groundbreaking Global Brain Cancer Trial Planned

11/21/2015

ReACT: Long-term survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma

11/21/2015

Phase I/II Study of Dianhydrogalactitol (Val-083) in Patients with Recurrent Malignant Glioma

11/20/2015

Celldex vaccine improves long-term brain cancer survival in study

11/20/2015

New Phase 3 Data show Optune in Combination with Second Line Chemotherapy is Superior to Second Line Chemotherapy Alone in Glioblastoma Patients at First Recurrence

Our privacy / cookie policy has changed.
Click HERE to read it!